Research ArticleArticle
High Disease Activity Is Associated with Self-reported Depression and Predicts Persistent Depression in Early Rheumatoid Arthritis: Results from the Ontario Best Practices Research Initiative
Bindee Kuriya, Raman Joshi, Mohammad Movahedi, Emmanouil Rampakakis, John S. Sampalis, Claire Bombardier and Ontario Best Practices Research Initiative Investigators
The Journal of Rheumatology May 2018, jrheum.171195; DOI: https://doi.org/10.3899/jrheum.171195
Bindee Kuriya
From the Sinai Health System, University of Toronto; Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto; Brampton Civic Hospital, William Osler Health System, Brampton, Ontario; JSS Medical Research, St. Laurent; McGill University, Montreal, Quebec, Canada. Dr. Kuriya was the recipient of the Canadian Rheumatology Association/The Arthritis Society Clinician Investigator Award. OBRI is funded by peerreviewed grants from the Canadian Institute for Health Research (CIHR), Ontario Ministry of Health and Long-Term Care, Canadian Arthritis Network and unrestricted grants from Abbvie, Amgen, Bristol Myers Squibb, Pfizer, UCB, Janssen and Roche, Celgene, Fresenius Kabi. B. Kuriya, MD, FRCPC, SM, Sinai Health System, University of Toronto; R. Joshi, MD, Brampton Civic Hospital, William Osler Health System; M. Movahedi, MD, PhD, Toronto General Hospital Research Institute, University Health Network, University of Toronto, and JSS Medical Research; E. Rampakakis, PhD, JSS Medical Research, S. Sampalis, PhD, JSS Medical Research, and McGill University; C. Bombardier, MD, FRCPC, MSc, Sinai Health System, University of Toronto, and Toronto General Hospital Research Institute, University Health Network, University of Toronto. Address correspondence to Dr. B. Kuriya, Division of Rheumatology, Sinai Health System, The Joseph and Wolf Lebovic Building, 60 Murray Street, Room 2-008, Toronto, Ontario M5T 3L9, Canada. E-mail: bindee.kuriya@sinaihealthsystem.ca. Accepted for publication February 12, 2018.
Raman Joshi
From the Sinai Health System, University of Toronto; Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto; Brampton Civic Hospital, William Osler Health System, Brampton, Ontario; JSS Medical Research, St. Laurent; McGill University, Montreal, Quebec, Canada. Dr. Kuriya was the recipient of the Canadian Rheumatology Association/The Arthritis Society Clinician Investigator Award. OBRI is funded by peerreviewed grants from the Canadian Institute for Health Research (CIHR), Ontario Ministry of Health and Long-Term Care, Canadian Arthritis Network and unrestricted grants from Abbvie, Amgen, Bristol Myers Squibb, Pfizer, UCB, Janssen and Roche, Celgene, Fresenius Kabi. B. Kuriya, MD, FRCPC, SM, Sinai Health System, University of Toronto; R. Joshi, MD, Brampton Civic Hospital, William Osler Health System; M. Movahedi, MD, PhD, Toronto General Hospital Research Institute, University Health Network, University of Toronto, and JSS Medical Research; E. Rampakakis, PhD, JSS Medical Research, S. Sampalis, PhD, JSS Medical Research, and McGill University; C. Bombardier, MD, FRCPC, MSc, Sinai Health System, University of Toronto, and Toronto General Hospital Research Institute, University Health Network, University of Toronto. Address correspondence to Dr. B. Kuriya, Division of Rheumatology, Sinai Health System, The Joseph and Wolf Lebovic Building, 60 Murray Street, Room 2-008, Toronto, Ontario M5T 3L9, Canada. E-mail: bindee.kuriya@sinaihealthsystem.ca. Accepted for publication February 12, 2018.
Mohammad Movahedi
From the Sinai Health System, University of Toronto; Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto; Brampton Civic Hospital, William Osler Health System, Brampton, Ontario; JSS Medical Research, St. Laurent; McGill University, Montreal, Quebec, Canada. Dr. Kuriya was the recipient of the Canadian Rheumatology Association/The Arthritis Society Clinician Investigator Award. OBRI is funded by peerreviewed grants from the Canadian Institute for Health Research (CIHR), Ontario Ministry of Health and Long-Term Care, Canadian Arthritis Network and unrestricted grants from Abbvie, Amgen, Bristol Myers Squibb, Pfizer, UCB, Janssen and Roche, Celgene, Fresenius Kabi. B. Kuriya, MD, FRCPC, SM, Sinai Health System, University of Toronto; R. Joshi, MD, Brampton Civic Hospital, William Osler Health System; M. Movahedi, MD, PhD, Toronto General Hospital Research Institute, University Health Network, University of Toronto, and JSS Medical Research; E. Rampakakis, PhD, JSS Medical Research, S. Sampalis, PhD, JSS Medical Research, and McGill University; C. Bombardier, MD, FRCPC, MSc, Sinai Health System, University of Toronto, and Toronto General Hospital Research Institute, University Health Network, University of Toronto. Address correspondence to Dr. B. Kuriya, Division of Rheumatology, Sinai Health System, The Joseph and Wolf Lebovic Building, 60 Murray Street, Room 2-008, Toronto, Ontario M5T 3L9, Canada. E-mail: bindee.kuriya@sinaihealthsystem.ca. Accepted for publication February 12, 2018.
Emmanouil Rampakakis
From the Sinai Health System, University of Toronto; Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto; Brampton Civic Hospital, William Osler Health System, Brampton, Ontario; JSS Medical Research, St. Laurent; McGill University, Montreal, Quebec, Canada. Dr. Kuriya was the recipient of the Canadian Rheumatology Association/The Arthritis Society Clinician Investigator Award. OBRI is funded by peerreviewed grants from the Canadian Institute for Health Research (CIHR), Ontario Ministry of Health and Long-Term Care, Canadian Arthritis Network and unrestricted grants from Abbvie, Amgen, Bristol Myers Squibb, Pfizer, UCB, Janssen and Roche, Celgene, Fresenius Kabi. B. Kuriya, MD, FRCPC, SM, Sinai Health System, University of Toronto; R. Joshi, MD, Brampton Civic Hospital, William Osler Health System; M. Movahedi, MD, PhD, Toronto General Hospital Research Institute, University Health Network, University of Toronto, and JSS Medical Research; E. Rampakakis, PhD, JSS Medical Research, S. Sampalis, PhD, JSS Medical Research, and McGill University; C. Bombardier, MD, FRCPC, MSc, Sinai Health System, University of Toronto, and Toronto General Hospital Research Institute, University Health Network, University of Toronto. Address correspondence to Dr. B. Kuriya, Division of Rheumatology, Sinai Health System, The Joseph and Wolf Lebovic Building, 60 Murray Street, Room 2-008, Toronto, Ontario M5T 3L9, Canada. E-mail: bindee.kuriya@sinaihealthsystem.ca. Accepted for publication February 12, 2018.
John S. Sampalis
From the Sinai Health System, University of Toronto; Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto; Brampton Civic Hospital, William Osler Health System, Brampton, Ontario; JSS Medical Research, St. Laurent; McGill University, Montreal, Quebec, Canada. Dr. Kuriya was the recipient of the Canadian Rheumatology Association/The Arthritis Society Clinician Investigator Award. OBRI is funded by peerreviewed grants from the Canadian Institute for Health Research (CIHR), Ontario Ministry of Health and Long-Term Care, Canadian Arthritis Network and unrestricted grants from Abbvie, Amgen, Bristol Myers Squibb, Pfizer, UCB, Janssen and Roche, Celgene, Fresenius Kabi. B. Kuriya, MD, FRCPC, SM, Sinai Health System, University of Toronto; R. Joshi, MD, Brampton Civic Hospital, William Osler Health System; M. Movahedi, MD, PhD, Toronto General Hospital Research Institute, University Health Network, University of Toronto, and JSS Medical Research; E. Rampakakis, PhD, JSS Medical Research, S. Sampalis, PhD, JSS Medical Research, and McGill University; C. Bombardier, MD, FRCPC, MSc, Sinai Health System, University of Toronto, and Toronto General Hospital Research Institute, University Health Network, University of Toronto. Address correspondence to Dr. B. Kuriya, Division of Rheumatology, Sinai Health System, The Joseph and Wolf Lebovic Building, 60 Murray Street, Room 2-008, Toronto, Ontario M5T 3L9, Canada. E-mail: bindee.kuriya@sinaihealthsystem.ca. Accepted for publication February 12, 2018.
Claire Bombardier
From the Sinai Health System, University of Toronto; Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto; Brampton Civic Hospital, William Osler Health System, Brampton, Ontario; JSS Medical Research, St. Laurent; McGill University, Montreal, Quebec, Canada. Dr. Kuriya was the recipient of the Canadian Rheumatology Association/The Arthritis Society Clinician Investigator Award. OBRI is funded by peerreviewed grants from the Canadian Institute for Health Research (CIHR), Ontario Ministry of Health and Long-Term Care, Canadian Arthritis Network and unrestricted grants from Abbvie, Amgen, Bristol Myers Squibb, Pfizer, UCB, Janssen and Roche, Celgene, Fresenius Kabi. B. Kuriya, MD, FRCPC, SM, Sinai Health System, University of Toronto; R. Joshi, MD, Brampton Civic Hospital, William Osler Health System; M. Movahedi, MD, PhD, Toronto General Hospital Research Institute, University Health Network, University of Toronto, and JSS Medical Research; E. Rampakakis, PhD, JSS Medical Research, S. Sampalis, PhD, JSS Medical Research, and McGill University; C. Bombardier, MD, FRCPC, MSc, Sinai Health System, University of Toronto, and Toronto General Hospital Research Institute, University Health Network, University of Toronto. Address correspondence to Dr. B. Kuriya, Division of Rheumatology, Sinai Health System, The Joseph and Wolf Lebovic Building, 60 Murray Street, Room 2-008, Toronto, Ontario M5T 3L9, Canada. E-mail: bindee.kuriya@sinaihealthsystem.ca. Accepted for publication February 12, 2018.
From the Sinai Health System, University of Toronto; Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto; Brampton Civic Hospital, William Osler Health System, Brampton, Ontario; JSS Medical Research, St. Laurent; McGill University, Montreal, Quebec, Canada. Dr. Kuriya was the recipient of the Canadian Rheumatology Association/The Arthritis Society Clinician Investigator Award. OBRI is funded by peerreviewed grants from the Canadian Institute for Health Research (CIHR), Ontario Ministry of Health and Long-Term Care, Canadian Arthritis Network and unrestricted grants from Abbvie, Amgen, Bristol Myers Squibb, Pfizer, UCB, Janssen and Roche, Celgene, Fresenius Kabi. B. Kuriya, MD, FRCPC, SM, Sinai Health System, University of Toronto; R. Joshi, MD, Brampton Civic Hospital, William Osler Health System; M. Movahedi, MD, PhD, Toronto General Hospital Research Institute, University Health Network, University of Toronto, and JSS Medical Research; E. Rampakakis, PhD, JSS Medical Research, S. Sampalis, PhD, JSS Medical Research, and McGill University; C. Bombardier, MD, FRCPC, MSc, Sinai Health System, University of Toronto, and Toronto General Hospital Research Institute, University Health Network, University of Toronto. Address correspondence to Dr. B. Kuriya, Division of Rheumatology, Sinai Health System, The Joseph and Wolf Lebovic Building, 60 Murray Street, Room 2-008, Toronto, Ontario M5T 3L9, Canada. E-mail: bindee.kuriya@sinaihealthsystem.ca. Accepted for publication February 12, 2018.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
High Disease Activity Is Associated with Self-reported Depression and Predicts Persistent Depression in Early Rheumatoid Arthritis: Results from the Ontario Best Practices Research Initiative
Bindee Kuriya, Raman Joshi, Mohammad Movahedi, Emmanouil Rampakakis, John S. Sampalis, Claire Bombardier, Ontario Best Practices Research Initiative Investigators
The Journal of Rheumatology May 2018, jrheum.171195; DOI: 10.3899/jrheum.171195
High Disease Activity Is Associated with Self-reported Depression and Predicts Persistent Depression in Early Rheumatoid Arthritis: Results from the Ontario Best Practices Research Initiative
Bindee Kuriya, Raman Joshi, Mohammad Movahedi, Emmanouil Rampakakis, John S. Sampalis, Claire Bombardier, Ontario Best Practices Research Initiative Investigators
The Journal of Rheumatology May 2018, jrheum.171195; DOI: 10.3899/jrheum.171195